Stocks and Investing Stocks and Investing
Thu, July 20, 2023
Wed, July 19, 2023
Tue, July 18, 2023

Edward Nash Maintained (TVTX) at Strong Buy with Decreased Target to $35 on, Jul 18th, 2023


Published on 2024-10-28 04:54:33 - WOPRAI, Edward Nash
  Print publication without navigation


Edward Nash of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $37 to $35 on, Jul 18th, 2023.

Edward has made no other calls on TVTX in the last 4 months.



There are 8 other peers that have a rating on TVTX. Out of the 8 peers that are also analyzing TVTX, 1 agrees with Edward's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Nicole Gabreski of "Piper Sandler" Initiated at Hold and Held Target at $22 on, Wednesday, June 7th, 2023


These are the ratings of the 7 analyists that currently disagree with Edward


  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $23 on, Wednesday, June 21st, 2023
  • Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $35 on, Thursday, June 1st, 2023
  • Tyler Van Buren of "TD Cowen" Initiated at Buy and Held Target at $30 on, Monday, May 22nd, 2023
  • Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
  • Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023